% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • xwavve xwavve Dec 26, 2012 6:42 PM Flag

    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

    1300 patient cabo trial -- scheduled for completion this month for primary end-point, according to ClinTrials.

    Top-line data should be forthcoming in the next few months. These type of data may result in a much broader label than people expect, and accelerate compendium listing/off-label use.

    Look for a European partner announcement in Q.1...

    Look for compendium listing beyond MTC in late Q.1-2..

    Much off-label use on the way.....

    Hmmmmm. This would seem like big news in Q.1 - - 1300 Patient Trial

    SortNewest  |  Oldest  |  Most Replied Expand all replies
5.95-0.10(-1.65%)Aug 31 4:00 PMEDT